Back to top
more

Intuitive Surgical (ISRG)

(Delayed Data from NSDQ)

$486.62 USD

486.62
740,884

+1.86 (0.38%)

Updated Oct 2, 2024 04:00 PM ET

After-Market: $487.17 +0.55 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 20% (50 out of 252)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Quest Diagnostics Plans a Buyout to Widen TB Testing Suite

Quest Diagnostics (DGX) progresses well with regard to its strategy to grow inorganically.

    The Zacks Analyst Blog Highlights: Alphabet, Bank of America, PepsiCo, Eli Lilly and Intuitive Surgical

    The Zacks Analyst Blog Highlights: Alphabet, Bank of America, PepsiCo, Eli Lilly and Intuitive Surgical

      STERIS (STE) Strategic Growth Strong Amid Several Headwinds

      STERIS (STE) impresses with favorable underlying market trends apart from new products and service offerings. Yet, a severe competition lurking beneath is worrisome for the company.

        Mark Vickery headshot

        Top Research Reports for Alphabet, Bank of America & PepsiCo

        Today's Research Daily features new research reports on 16 major stocks, including Alphabet (GOOGL), Bank of America (BAC), and PepsiCo (PEP).

          Quest Diagnostics Inks Lab Service Deal With ReproSource

          Per agreement with ReproSource, Quest Diagnostics (DGX) to perform laboratory reference testing besides providing supply chain expertise.

            Abbott's Troponin-I Wins CE Mark, Vascular Arm Gets a Revamp

            Abbott's (ABT) life-changing High Sensitive Troponin-I test uses a biomarker, specific to the heart.

              Hologic's Focal Therapeutics Buyout to Boost Breast Health Arm

              Hologic (HOLX) progresses with initiatives to boost the Breast Health unit. The recent buyout is likely to widen portfolio and fortify Hologic's position in the breast conserving surgery market.

                Here's Why You Should Add Edwards Lifesciences Right Away

                We are upbeat about the continued strength in Edwards Lifesciences' (EW) THVT business.

                  Will LabCorp's (LH) Food Solution Divestment Upset Sales?

                  LabCorp's (LH) lackluster outlook for 2018 includes the earlier-announced divestment of its Food Solutions business.

                    Neogen (NEOG) Earnings Beat, Revenues Lag Estimates in Q1

                    Accretive integrations and an expanding international footprint drive Neogen's (NEOG) earnings in Q1.

                      Is Intuitive Surgical (ISRG) Outperforming Other Medical Stocks This Year?

                      Is (ISRG) Outperforming Other Medical Stocks This Year?

                        Here's Why You Should Invest in Walgreens Boots Stock Now

                        Walgreens Boots (WBA) gains from tie-ups. The company's alliance with Express Scripts encourages.

                          Boston Scientific's FDA Nod for Eluvia Stent Expands PI Suite

                          Boston Scientific's (BSX) PMA approval for Eluvia Drug-Eluting Vascular Stent System will help boost the top line at the PI business.

                            Intuitive Surgical and InTouch Collaborate for IoMT Services

                            Intuitive Surgical's (ISRG) IoMT likely to benefit patients; market prospects impressive.

                              Here's Why You Should Buy Intuitive Surgical (ISRG) Now

                              Strength in the surgical platform and a string of developments make Intuitive Surgical (ISRG) a promising pick.

                                Medtronic to Buy Mazor Robotics for Robotic Spine Surgery

                                The consolidation will combine Medtronic's (MDT) spine implants, navigation and intra-operative imaging technology with Mazor Robotics' robotic-assisted surgery (RAS) systems.

                                  Sweta Jaiswal headshot

                                  3 MedTech Stocks for Safe Returns as Hurricane Fears Peak

                                  With the hurricane season at the peak, we bring three safe picks for investors.

                                    Cerner's CommunityWorks Picked by Reeves County Hospital

                                    Cerner (CERN) sees a slew of developments in its EHR platform, market prospects bright.

                                      Here's Why You Should Hold Becton, Dickinson (BDX) Stock Now

                                      Becton, Dickinson (BD) is likely to gain from expansion into emerging overseas markets.

                                        Abbott Banks on New Approvals and Buyouts, Competition Rife

                                        Abbott's (ABT) receipt of FDA approval for XIENCE Sierra coronary stent system as well as a reimbursement approval in Japan for the same device will help it revive the dull Vascular business.

                                          Cardiovascular Systems Stealth 360 Peripheral OAS Goes Global

                                          Following the recent extension of its partnership with OrbusNeich, Cardiovascular Systems' (CSII) Stealth 360 Peripheral OAS is put to first commercial use in Hong Kong.

                                            Cerner Integrated Platform Implemented by Spectrum Health

                                            Spectrum Health selects Cerner's (CERN) Cerner Integrated Platform to treat psychological disorders.

                                              Insulet Advances on Omnipod Reimbursement Update, Runs Risks

                                              Insulet (PODD) commences 2018 with favorable reimbursement updates. The company attains several landmarks regarding Omnipod's market reach.

                                                Here's Why You Should Hold on to Align Technology (ALGN) Now

                                                Continued strength in Align Technology's (ALGN) Invisalign volumes impresses. Overdependence on Invisalign Technology system is a concern.

                                                  Here's Why You Should Hold AngioDynamics' (ANGO) Stock Now

                                                  AngioDynamics (ANGO) to benefit from a solid product portfolio. However, the company???s core Peripheral Vascular business has been sluggish.